Skip to main content

Gypsyamber
D'Souza
,
PhD

Professor

Departmental Affiliations

Primary
Division
Cancer Epidemiology
Joint
Division
Global Disease Epidemiology and Control
School of Medicine
Joint

Center & Institute Affiliations

Gypsyamber D’Souza, PhD '07, MS, MPH, researches infectious diseases and cancer prevention, focusing on translational epidemiology to answer patient and policy questions.

Contact Info

615 N. Wolfe Street, Room E6132B
Baltimore
Maryland
21205
US        

Research Interests

risk behavior; infectious disease epidemiology; global cancer; HPV; HIV; STD; translational epidemiology; cohort studies; epidemiology methods; datacenter

Experiences & Accomplishments
Education
PhD
Johns Hopkins Bloomberg School of Public Health
2007
MPH
University of Texas Health Science Center
2001
MS
University of Wisconsin, Madison
1999
BA
Swarthmore College
1996
Overview

Dr. D'Souza's primary research interest is in infectious disease, risk behaviors, and translational epidemiology. She leads a research program on HPV and related cancers, risk triage and risk communication. In addition Dr. D'Souza is a PI of the MACS-WIHS Combined Cohort Study, a large multisite study of HIV in the U.S.

Honors & Awards

2016-current Member of the NIH National Cancer Institute HPV Vaccine Trial Working Group

2007 Research cited as one of top six advances in cancer research in 2007 by the American Society of Clinical Oncology (ASCO)

1995 Received the Gold U.S. Congressional award, recognizing initiative, achievement and service

Select Publications

Example publications

  • D'Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, Bishop J, Quon H, Kiess AP, Richmon JD, Eisele DW, Fakhry C. Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method. JAMA Oncol. 2016 Dec 8. PMID: 27930766.

  • Fakhry C, D'Souza G. Discussing the diagnosis of HPV-OSCC: Common questions and answers. Oral Oncology. 2013 Jul 16. PMID:23876627.

  • Carethers JM, Sengupta R, Blakey R, Ribas A, D'Souza G. Disparities in Cancer Prevention in the COVID-19 Era. Cancer Prev Res (Phila). 2020 Nov;13(11):893-896. PMID: 32943438

  • D'Souza G, Golub ET, Gange SJ. The Changing Science of HIV Epidemiology in the U.S. American Journal of Epidemiology. 2019 Oct 8. pii: kwz211. PMID:31595945

  • Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkhoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, D’Souza G. Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach. AIDS. 2017 Apr 24;31(7):1035-1044. PMID:28323758

  • D'Souza G, Tewari SR et al.  Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study. Cancer. 2023 Aug 1;129(15):2373-2384. doi: 10.1002/cncr.34783. Epub 2023 Apr 9.PMID: 37032449 . 

Projects
Men Offering Understanding of Throat Hpv (MOUTH)
MACS-WIHS Combined Cohort Study